Clinical trial

Extracorporeal SPecific IgE Removal From the Plasma of Allergic Asthma Patients (ESPIRA-study)

NCT02096237

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-12-01

PhaseNA

Study timeline

Study start (unknown)2013-12-01Date precision: month

Registry last updated2015-03-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Allergic Asthmaunresolved

Interventions

IgE adsorberDEVICE

Sponsors & collaborators

Fresenius Medical Care Deutschland GmbHlead sponsor

Mapped research locations

ViennaAustria1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02096237 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.